Skip to content
Clinical ResearchResearch compoundModerate evidence

Seltorexant

Experimental drug candidate for sleep problems and depression that blocks the wakefulness signal of orexin; not yet approved.

Sleep AidOrexin AntagonistOrexin AntagonistSleep Supportnoo.affects.orexinnoo.affects.sleepnoo.affects.mood-support

Pharmacology

ClassOrexin Antagonist · Sleep Support
Primary targetSelective orexin-2 (OX2R) receptor antagonist
Targets3 receptor targets
Half-life~2-3 hours (short, designed to minimize residual sedation)
OnsetTaken at bedtime, shortly before sleep
EvidenceModerate evidence
Affected systemsnoo.affects.orexinnoo.affects.sleepnoo.affects.mood-support

Contents

DETAILED OVERVIEW

What is Seltorexant?

Seltorexant is an experimental drug candidate that the pharmaceutical company Janssen is developing for sleep problems and major depression. It is not approved as a medicine in any country, it is not a dietary supplement, and it is used only within clinical trials.

In the brain, a messenger called orexin keeps a person awake; seltorexant blocks one of its receptors and largely spares the other. In studies people fell asleep faster, slept longer and stayed asleep better, and compared with placebo depression also eased, mainly where poor sleep was present as well. Side effects can include next-day drowsiness, headache, dizziness and tiredness. Together with alcohol and other sedating substances the drowsy effect adds up. It is contraindicated in narcolepsy (a condition involving a lack of orexin), and its safety in pregnancy and breastfeeding has not been established.

Mechanism

Selective OX2R antagonist

Half-life

~2-3 hours

Legal status

Investigational (Phase 3), not approved

Receptor profile

  • Orexin-2 receptor (OX2R)Strong
  • Wakefulness drive suppressionStrong
  • Orexin-1 receptor (OX1R, spared)Weak

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Next-day grogginess, somnolence, occasionally residual sedation
  • Headache
  • Mild dizziness
  • Mild fatigue
  • Vivid dreams or sleep paralysis theoretically possible with orexin antagonists (rare)

Contraindications · 4

  • Pregnancy and breastfeeding: safety not established, avoid
  • Narcolepsy or other orexin-deficient states: further blockade of orexin signaling is contraindicated
  • Additive sedation with other CNS depressants (alcohol, benzodiazepines, opioids)
  • Investigational compound: not an approved medicine, not for use outside clinical supervision

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Seltorexant is an investigational drug being studied for sleep problems and depression, particularly cases where poor sleep and depression occur together. It works by dialing down a brain signal that keeps you awake, helping you fall asleep faster and sleep more soundly. In trials it shortened time to fall asleep, improved total sleep time and mood, and was reported to be well tolerated. Important: this is still in clinical development, not an approved, marketed drug.

Telegram

Have a question about Seltorexant?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeSleep Aid
FormulaC21H22FN7O
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.